methylphenidate modified release capsules - 8 hrs acting / Generic mfg.  >>  Phase 2
Welcome,         Profile    Billing    Logout  

3 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
methylphenidate modified release capsules - 8 hrs acting / Generic mfg.
NCT00409708 / 2015-004444-19: Effects of Methylphenidate on Cellular Abnormalities in Children With Attention Deficit Hyperactivity Disorder (ADHD)

Completed
2
142
US
Extended Release Methylphenidate (Ritalin LA ) plus Behavior Therapy, Ritalin LA, Behavior Therapy
Novartis
Attention Deficit Hyperactivity Disorder
03/08
 
NCT01879202 / 2012-003418-15: Methylphenidate as Treatment Option of Fatigue in Multiple Sclerosis

Unknown status
2
96
Europe
Methylphenidate modified release, Ritalin LA 20mg, Ritalin LA 30mg, Ritalin LA 40mg, Maltodextrin, Placebo
Medical University of Vienna
Multiple Sclerosis, Fatigue
02/17
02/17
MPH-Kinetics, NCT00772161 / 2008-000227-25: Pharmacokinetics of Two Extended-Release Formulations of Methylphenidate in Children With Attention Deficit Hyperactivity Disorder (ADHD)

Completed
1/2
24
Europe
Methylphenidate, Ritalin LA, Medikinet retard
University Hospital Freiburg, Novartis
Attention Deficit Hyperactivity Disorder
12/08
12/08

Download Options